Callan Family Office’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$7.5M	Buy	108,592 +75,117	+224%	+$5.18M	0.24%	93
2025 Q1	$2.32M	Buy	33,475 +3,192	+11%	+$222K	0.17%	116
2024 Q4	$2.6M	Buy	+30,283	New	+$2.6M	0.17%	118